Medtronic plc (MDT) EPS Diluted: 3.73
Is Medtronic plc’s EPS diluted high or low?
Medtronic plc's EPS diluted of 3.73 is 16% above its 5-year average of 3.22, near the high end of its 5-year range (2.66–3.73).
The EPS diluted for Medtronic plc (MDT) is 3.73. It is above its 12-month average by 1.63% (3.67).
MDT EPS Diluted Chart
MDT Average EPS Diluted Chart
MDT Current vs Average EPS Diluted Chart
MDT EPS Diluted Metrics
EPS DILUTED
3.73
EPS DILUTED AVG TTM
3.67
EPS DILUTED AVG 3Y
3.23
EPS DILUTED AVG 5Y
3.22
EPS DILUTED AVG 10Y
3.08
EPS DILUTED AVG 15Y
3.06
EPS DILUTED AVG 20Y
2.86
CURRENT VS TTM AVG
+1.63%
CURRENT VS 3Y AVG
+15.48%
CURRENT VS 5Y AVG
+15.90%
CURRENT VS 10Y AVG
+21.03%
CURRENT VS 15Y AVG
+21.87%
CURRENT VS 20Y AVG
+30.44%
Medtronic plc EPS Diluted Formula & Definition
EPS Diluted includes the effect of convertible securities, options, and other potential shares. Compare it with basic EPS to see the impact of potential dilution.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Medtronic plc EPS Diluted FAQ
- What is the EPS diluted for Medtronic plc (MDT)?
- The EPS diluted for MDT stock is 3.73.
- Is Medtronic plc's EPS diluted high or low?
- Medtronic plc's EPS diluted of 3.73 is 16% above its 5-year average of 3.22, near the high end of its 5-year range (2.66–3.73).
- What is the TTM average EPS diluted for Medtronic plc (MDT)?
- The TTM average EPS diluted for MDT stock is 3.67.
- What is the 3Y average EPS diluted for Medtronic plc (MDT)?
- The 3Y average EPS diluted for MDT stock is 3.23.
- What is the 5Y average EPS diluted for Medtronic plc (MDT)?
- The 5Y average EPS diluted for MDT stock is 3.22.
- What is the 10Y average EPS diluted for Medtronic plc (MDT)?
- The 10Y average EPS diluted for MDT stock is 3.08.
- What is the 15Y average EPS diluted for Medtronic plc (MDT)?
- The 15Y average EPS diluted for MDT stock is 3.06.
- What is the 20Y average EPS diluted for Medtronic plc (MDT)?
- The 20Y average EPS diluted for MDT stock is 2.86.
Medtronic plc EPS Diluted History
| DATE | EPS DILUTED |
|---|---|
| 2026-04-24 | 3.73 |
| 2025-04-30 | 3.61 |
| 2024-04-30 | 2.76 |
| 2023-04-30 | 2.82 |
| 2022-04-30 | 3.73 |
| 2021-04-30 | 2.66 |
| 2020-04-30 | 3.54 |
| 2019-04-30 | 3.41 |
| 2018-04-30 | 2.27 |
| 2017-04-30 | 2.89 |
| 2016-04-30 | 2.48 |
| 2015-04-30 | 2.41 |
| 2014-04-30 | 3.02 |
| 2013-04-30 | 3.37 |
| 2012-04-30 | 3.41 |
| 2011-04-30 | 2.86 |
| 2010-04-30 | 2.79 |
| 2009-04-30 | 1.84 |
| 2008-04-30 | 1.95 |
| 2007-04-30 | 2.41 |
| 2006-04-30 | 2.09 |
| 2005-04-30 | 1.48 |
| 2004-04-30 | 1.60 |
| 2003-04-30 | 1.30 |
| 2002-04-30 | 0.80 |
| 2001-04-30 | 0.85 |
| 2000-04-30 | 0.89 |
| 1999-04-30 | 0.39 |
| 1998-04-30 | 0.51 |
| 1997-04-30 | 0.50 |
Related Metrics
About Medtronic plc
Medtronic plc is a leading global medical technology enterprise that invents, develops, manufactures, and distributes an extensive range of device-based medical therapies. These solutions serve healthcare systems, clinicians, physicians, and patients across the world. The company's operations are categorized into several key portfolios: Cardiovascular Portfolio: This segment focuses on cardiac health, providing technologies for heart rhythm management, including implantable pacemakers, defibrillators, and monitoring systems, alongside cardiac ablation tools and remote patient software. It also addresses structural heart issues with products like aortic and pulmonary valves, surgical repair devices, and endovascular stent grafts, in addition to offerings for percutaneous coronary interventions (e.g., angioplasty balloons). Medical Surgical Portfolio: Offering a broad spectrum of surgical instruments and therapies, this division includes staples, vessel sealing devices, wound closure products, and electrosurgical equipment. It also pioneers surgical artificial intelligence and robotic-assisted platforms, alongside solutions for hernia repair, gynecology, lung conditions, minimally invasive gastrointestinal and hepatologic diagnostics, patient monitoring, airway management, ventilation therapies, and renal disease. Neuroscience Portfolio: This division delivers specialized products for a diverse group of medical professionals, such as spinal surgeons, neurosurgeons, neurologists, pain management specialists, and ENT experts. Its offerings span energy surgical instruments, advanced image-guided and intra-operative imaging systems, robotic guidance for spine procedures, and therapies targeting the brain's vasculature. Diabetes Operating Unit: Dedicated to diabetes management, this unit provides innovative solutions like insulin pumps and their associated consumables, continuous glucose monitoring (CGM) systems, and smart insulin pen technologies. Established in 1949, Medtronic plc maintains its corporate headquarters in Dublin, Ireland.
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Geoffrey Straub Martha